Our data support the hypothesis that a short period of 6 months is insufficient to induce morphological changes in the carotid wall, but that such interventions can produce improvements in the serological markers of endothelial dysfunction, such as ICAM-1, and in the lipid-based atherogenic indices. The gene discussed is ICAM1; the disease is endothelial dysfunction.